Biochemical Assessment of Bone Health in Working Obese Egyptian Females with Metabolic Syndrome; the Effect of Weight Loss by Natural Dietary Therapies

Maha I.A. Moaty; Suzanne Fouad; Salwa M. El Shebini; Yusr I. Kazem; Salwa T. Tapozada

doi:10.3889/oamjms.2015.127

Authors

Maha I.A. Moaty National Research Centre, Nutrition and Food Sciences Department, Cairo
Suzanne Fouad National Research Centre, Nutrition and Food Sciences Department, Cairo
Salwa M. El Shebini National Research Centre, Nutrition and Food Sciences Department, Cairo
Yusr I. Kazem National Research Centre, Nutrition and Food Sciences Department, Cairo
Salwa T. Tapozada National Research Centre, Nutrition and Food Sciences Department, Cairo

DOI:

https://doi.org/10.3889/oamjms.2015.127

Keywords:

Vitamin D, Parathyroid hormones, Bone specific alkaline phosphatase, Doum, Metabolic syndrome

Abstract

AIM: To investigate the relation between bone parameters and the metabolic syndrome criteria, before and after the administration of two different natural dietary supplements in middle aged working obese Egyptian women suffering from metabolic syndrome (MetS).

SUBJECTS AND METHODS: Fifty eight middle aged obese female volunteers suffering from metabolic syndrome were divided into two groups. During the first period, group (A) consumed a low caloric diet and nutritional supplement consisting of doum flour biscuits, while group (B) consumed whole meal wheat flour biscuit with the same instructions. During the second period, both supplements were omitted. Assessment of blood pressure, relevant anthropometric parameters, lipid accumulation product, fasting blood glucose, uric acid, 25 hydroxy vitamin D (25 (OH) D), parathyroid hormone (PTH) and bone-specific alkaline phosphatase were performed.

RESULTS: Data showed that although both supplements improved the MetS criteria and the bone health parameters, the supplement containing the doum flour proved to be more effective.

CONCLUSION: These results confirm the benefit of doum in improving bone health parameter [25 (OH) D/PTH axis] in the MetS patients, beside the MetS criteria. So, we can conclude that natural effective supplements lead towards the optimization of biochemical parameters in favor of a healthy outcome.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Mottillo S, Filion KB, Genest J, et.al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56:1113-1132.

http://dx.doi.org/10.1016/j.jacc.2010.05.034 DOI: https://doi.org/10.1016/j.jacc.2010.05.034

PMid:20863953

Alberti K; Zimmet T. "Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications". World Health Organization, 2013: pp. 32â€“33.

Lips P. Worldwide status of vitamin D nutrition, J Steroid Biochem Mol Biol. 2010;121(1â€“2):297â€“300.

http://dx.doi.org/10.1016/j.jsbmb.2010.02.021 DOI: https://doi.org/10.1016/j.jsbmb.2010.02.021

PMid:20197091

Wielders JP, Wijnberg FA. Preanalytical stability of 25 (OH) vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem. 2009;55(8):1584-1585.

http://dx.doi.org/10.1373/clinchem.2008.117366

PMid:19541868

Soares MJ, Murhadi LL, Kurpad AV, et al. Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev. 2012;13(7):592â€“605.

http://dx.doi.org/10.1111/j.1467-789X.2012.00986.x DOI: https://doi.org/10.1111/j.1467-789X.2012.00986.x

PMid:22385576

Grethen E, McClintock R, Gupta CE, et al. Vitamin D and hyperparathyroidism in obesity. Journal of Clinical Endocrinology and Metabolism. 2011;96(5):1320â€“1326.

http://dx.doi.org/10.1210/jc.2010-2202 DOI: https://doi.org/10.1210/jc.2010-2202

PMid:21325456 PMCid:PMC3203623

Ku YC, Liu ME, Ku CS et al. Relationship between vitamin D deficiency and cardiovascular disease. World Journal of Cardiology. 2013;5(9):337â€“346.

http://dx.doi.org/10.4330/wjc.v5.i9.337 DOI: https://doi.org/10.4330/wjc.v5.i9.337

PMid:24109497 PMCid:PMC3783986

Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33:1379â€“1381.

http://dx.doi.org/10.2337/dc09-2321 DOI: https://doi.org/10.2337/dc09-2321

PMid:20215450 PMCid:PMC2875459

Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Annals of Internal Medicine. 2010;152 (5):307â€“314.

http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00009 DOI: https://doi.org/10.7326/0003-4819-152-5-201003020-00009

PMid:20194237 PMCid:PMC3211092

KarhapÃ¤Ã¤ P, PihlajamÃ¤ki J, PÃ¶rsti I, et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med. 2010;268:604â€“610.

http://dx.doi.org/10.1111/j.1365-2796.2010.02279.x DOI: https://doi.org/10.1111/j.1365-2796.2010.02279.x

PMid:20831628

Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PloS Medicine. 2013;10 (2).

http://dx.doi.org/10.1371/journal.pmed.1001383 DOI: https://doi.org/10.1371/journal.pmed.1001383

PMid:23393431 PMCid:PMC3564800

Kress BC. Bone alkaline phosphatase: methods of quantitation and clinical utility. J Clin Ligand Assay. 1998;21(2):139-148.

Kress BC, Mizrahi IA, Armour KW, et al.Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women. Clin Chem. 1999;45(7):1009-1017. DOI: https://doi.org/10.1093/clinchem/45.7.1009

PMid:10388477

AOAC. Official Methods of Analysis. Association of Official Analytical Chemist. EUA, 2000.

Gupta A, Gupta V. Metabolic syndrome: what are the risks for humans? Biosci Trends. 2010;4(5): 204-412.

PMid:21068471

Tanner JM, Hiernau J, Jerman S. Growth and physical studies In Human Biology: A guide to field methods. Eds Weiner JS,Lourie SA. IBP. London, Blackwell Scientific Publication. Oxford: UK, 1969.

Taverna MJ, MartÃnez-Larrad MT, Frechtel GD, et al. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol. 2011;164:559-567.

http://dx.doi.org/10.1530/EJE-10-1039 DOI: https://doi.org/10.1530/EJE-10-1039

PMid:21262912

Barham D, Trinder P. An improved color reagent for determination of blood glucose by oxidase system. Analyst. 1972;97:142-45.

http://dx.doi.org/10.1039/an9729700142 DOI: https://doi.org/10.1039/an9729700142

PMid:5037807

Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chemo. 2011; 20:470- 475. DOI: https://doi.org/10.1093/clinchem/20.4.470

Wornick DF, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res.1978;19:65-76. DOI: https://doi.org/10.1016/S0022-2275(20)41577-9

Wielders JP, Wijnberg FA. Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem. 2009;55 (8):1584-1585.

http://dx.doi.org/10.1373/clinchem.2008.117366 DOI: https://doi.org/10.1373/clinchem.2008.117366

PMid:19541868

Bouillon R, Coopmans W, De Groote D et al. Immunoradiometric assay of Parathyrin with polyclonal and monoclonal region specific antibodies. Clin Chem. 1990;36(2):271-276. DOI: https://doi.org/10.1093/clinchem/36.2.271

PMid:1689222

Garnero P, Delmas PD. Clinical usefulness of markers of bone remodeling in osteoporosis. In: Meunier PJ (ed.). Osteoporosis: Diagnosis and management. London: Martin Dunitz, 1998:79-101.

Fossati P, Prencipe L, Berti G. Use of 3, 5-Dichloro-2-hydroxy benzene sulfonic Acid/4-Ami nophenazone chromogenic system in direct enzymatic assay of uric acid in serum and urine. Clin Chem.1980;26(2):227-231. PMid:7353268 DOI: https://doi.org/10.1093/clinchem/26.2.0227

Hasler CM. A new look at an ancient concept. Chem. Industry Feb. 1998;2:84-89.

Abdel-Moaty M, Fouad S, El-Shebini S, et al. Serum Ceramide Kinase as a Biomarker of Cognitive Functions, and the Effect of Using Two Slimming Dietary Therapies in Obese Middle Aged Females. OA Maced J Med Sci. 2015;3(1):18-25.

http://dx.doi.org/10.3889/oamjms.2015.030 DOI: https://doi.org/10.3889/oamjms.2015.030

Abdel-Moaty M, El-Shebini S, Ahmed N, et al. Serum Level of the Adipokine "Vaspin" in Relation to Metabolic Parameters: Short â€“ Term Effect of Specific Dietary Therapy. Maced J Med Sci. 2014;7(2):185-190.

http://dx.doi.org/10.3889/oamjms.2014.029 DOI: https://doi.org/10.3889/oamjms.2014.029

DesprÃ©s, J.P., I. Lemieux, J. Bergeron, P. et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiovascular risk.Arterioscler Thromb Vasc Biol. 2008;28:1039-1049.

http://dx.doi.org/10.1161/ATVBAHA.107.159228 DOI: https://doi.org/10.1161/ATVBAHA.107.159228

PMid:18356555

Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367-373.

http://dx.doi.org/10.2174/1573399810602040367 DOI: https://doi.org/10.2174/1573399810602040367

PMid:18220642

Wortsman J, Matsuoka L, Chen T, et al. Decreased bioavailability of vitamin D in obesity. American Journal Clinical Nutrition. 2000;72(3):690â€“693. PMid:10966885 DOI: https://doi.org/10.1093/ajcn/72.3.690

Mawer E, Backhouse J, Holman C, et al. The distribution and storage of vitamin D and its metabolites in human tissues. Clinical Science. 1972; 43 (3): 413â€“431.

http://dx.doi.org/10.1042/cs0430413 DOI: https://doi.org/10.1042/cs0430413

PMid:4342673

Targher G, Bertolini L, Scala L, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases. 2007;17(7):517â€“524.

http://dx.doi.org/10.1016/j.numecd.2006.04.002 DOI: https://doi.org/10.1016/j.numecd.2006.04.002

PMid:16928437

Ding C, Parameswaran V, Blizzard L, et al. Not a simple fat-soluble vitamin: changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults. Journal of Internal Medicine. 2010;268(5):501â€“510.

http://dx.doi.org/10.1111/j.1365-2796.2010.02267.x DOI: https://doi.org/10.1111/j.1365-2796.2010.02267.x

PMid:20804516

Tzotzas T, Papadopoulou FG, Tziomalos K, et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance, J Clin Endocrinol Metab. 2010;95(5):4251.

http://dx.doi.org/10.1210/jc.2010-0757 DOI: https://doi.org/10.1210/jc.2010-0757

PMid:20534751

Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. Journal of Clinical Endocrinology and Metabolism. 2005;90:4119â€“4123.

http://dx.doi.org/10.1210/jc.2005-0216 DOI: https://doi.org/10.1210/jc.2005-0216

PMid:15855256

Portale AA & Miller WL. Human 25-hydroxylation D-1ahydroxylase: cloning, mutations, and gene expression. Pediatric Nephrology. 2000;14: 620â€“625.

http://dx.doi.org/10.1007/PL00009639 DOI: https://doi.org/10.1007/PL00009639

PMid:10912530

Schiele F, Henny J, Hitz J, et al. Total bone and liver alkaline phosphatase in plasma: biological variations and reference limits. Clin Chem. 1983; 29:634-641. DOI: https://doi.org/10.1093/clinchem/29.4.634

PMid:6831690

Ishizaka N, Ishizaka Y, Toda E, et al. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005; 25:1038-1044.

http://dx.doi.org/10.1161/01.ATV.0000161274.87407.26 DOI: https://doi.org/10.1161/01.ATV.0000161274.87407.26

PMid:15746438

Castrop H. Mediators of tubuloglomerular feedback regulation of glomerular filtration: ATP and adenosine. Acta Physiol (Oxf). 2007;189:3-14.

http://dx.doi.org/10.1111/j.1748-1716.2006.01610.x DOI: https://doi.org/10.1111/j.1748-1716.2006.01610.x

PMid:17280552

Makovey J, Macara M, Chen JS, Hayward CS, March L, Seibel MJ, Sambrook PN. Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone. 2013;52(1):400-406.

http://dx.doi.org/10.1016/j.bone.2012.10.025 DOI: https://doi.org/10.1016/j.bone.2012.10.025

PMid:23111314